Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides

Molecular Pharmaceutics

Volumn 6, Issue 3, 2009, Pages 1036-1039

  Pertinhez, Thelma A ^a   Conti, Stefania ^a   Ferrari, Elena ^a   Magliani, Walter ^a   Spisni, Alberto ^a   Polonelli, Luciano ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Drug delivery; Killer peptide; Laminarin; Peptide self assembly

Indexed keywords

BETA 1,3 GLUCAN; BETA GLUCAN; KILLER PEPTIDE; PEPTIDE; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CATALYSIS; CIRCULAR DICHROISM; DIMERIZATION; DISSOCIATION; DRUG DELIVERY SYSTEM; DRUG RESEARCH; DRUG STRUCTURE; FIBER; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PROCESSING; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; CANDIDA ALBICANS; CIRCULAR DICHROISM; KILLER FACTORS, YEAST; MICROSCOPY, ELECTRON; OLIGOPEPTIDES;

EID: 67249127511     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp900024z     Document Type: Article

References (20)

1. Putney, S. D.; Burke, P. A. Improving protein therapeutics with sustained-release formulations. Nat. Biotechnol. 1998, 16, 153-157. (Pubitemid 128723585)
2. Maji, S. K.; Schubert, D.; Rivier, C.; Lee, S.; Rivier, J. R.; Riek, R. Amyloid as a depot for the formulation of long-lasting drugs. PLoS Biol. 2008, 6, 240-252. (Pubitemid 351329046)
3. Lin, C. C.; Metters, A. T. Hydrogels in controlled release formulations: network design and mathematical modeling. Adv. Drug Delivery Rev. 2006, 58, 1379-1408. (Pubitemid 44778915)
4. Lutolf, M. P.; Hubbell, J. A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 2005, 23, 47-55. (Pubitemid 41724624)
5. Mikos, A. G.; Herring, S. W.; Ochareon, P.; Elisseeff, J.; Lu, H. H.; Kandel, R.; Schoen, F. J.; Toner, M.; Mooney, D.; Atala, A.; Van Dyke, M. E.; Kaplan, D.; Vunjak-Novakovic, G. Engineering complex tissues. Tissue Eng. 2006, 12, 3307-3339. (Pubitemid 46037158)
6. Stevens, M. M.; George, J. H. Exploring and engineering the cell surface interface. Science 2005, 310, 1135-1138. (Pubitemid 41681731)
7. Magliani, W.; Conti, S.; De Bernardis, F.; Gerloni, M.; Bertolotti, D.; Mozzoni, P.; Cassone, A.; Polonelli, L. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat. Biotechnol. 1997, 15, 155-158. (Pubitemid 27081781)
8. Beninati, C.; Oggioni, M. R.; Boccanera, M.; Spinosa, M. R.; Maggi, T.; Conti, S.; Magliani, W.; De Bernardis, F.; Teti, G.; Cassone, A.; Pozzi, G.; Polonelli, L. Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat. Biotechnol. 2000, 18, 1060-1064. (Pubitemid 30775849)
9. Polonelli, L.; Magliani, W.; Conti, S.; Bracci, L.; Lozzi, L.; Neri, P.; Adriani, D.; De Bernardis, F.; Cassone, A. Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis. Infect. Immun. 2003, 71, 6205-6212. (Pubitemid 37337676)
10. Casoli, C.; Pilotti, E.; Perno, C. F.; Balestra, E.; Polverini, E.; Cassone, A.; Conti, S.; Magliani, W.; Polonelli, L. A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication. AIDS 2006, 20, 975-980.
11. Cenci, E.; Bistoni, F.; Mencacci, A.; Perito, S.; Magliani, W.; Conti, S.; Polonelli, L.; Vecchiarelli, A. A synthetic peptide as a novel anticryptococcal agent. Cell. Microbiol. 2004, 6, 953-961. (Pubitemid 39255608)
12. Cenci, E.; Pericolini, E.; Mencacci, A.; Conti, S.; Magliani, W.; Bistoni, F.; Polonelli, L.; Vecchiarelli, A. Modulation of phenotype and function of dendritic cells by a therapeutic synthetic killer peptide. J. Leukocyte Biol. 2006, 79, 40-45. (Pubitemid 43054248)
13. Conti, G.; Magliani, W.; Conti, S.; Nencioni, L.; Sgarbanti, R.; Palamara, A. T.; Polonelli, L. Therapeutic activity of an antiidiotypic antibody-derived killer peptide 1 against influenza A virus experimental infection. Antimicrob. Agents Chemother. 2008, 52, 4331-4337.
14. Fiori, P. L.; Mattana, A.; Dessì, D.; Conti, S.; Magliani, W.; Polonelli, L. In Vitro acanthamoebicidal activity of a killer monoclonal antibody and a synthetic peptide. J. Antimicrob. Chemother. 2006, 57, 891-898.
15. Manfredi, M.; McCullough, M. J.; Conti, S.; Polonelli, L.; Vescovi, P.; Al Karaawi, Z. M.; Porter, S. R. In Vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals. Oral Microbiol. Immunol. 2005, 20, 226-232. (Pubitemid 40868396)
16. Savoia, D.; Scutera, S.; Raimondo, S.; Conti, S.; Magliani, W.; Polonelli, L. Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. Exp. Parasitol. 2006, 113, 186-192. (Pubitemid 43817976)
17. Travassos, L. R.; Silva, L. S.; Rodrigues, E. G.; Conti, S.; Salati, A.; Magliani, W.; Polonelli, L. Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis. J. Antimicrob. Chemother. 2004, 54, 956-958. (Pubitemid 39529994)
18. Pertinhez, T. A.; Bouchard, M.; Smith, R. A. G.; Dobson, C. M.; Smith, L. J. FEBS Lett. 2002, 529, 193-197.
19. Gantner, B. N.; Simmons, R. M.; Underhill, D. M. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J. 2005, 24, 1277-1286. (Pubitemid 40516610)
20. Ramachandran, S.; Tseng, Y.; Yu, B. Y. Repeated rapid shear-responsiveness of peptide hydrogels with tunable shear module. Biomacromolecules 2005, 6, 1316-1321. (Pubitemid 40775047)